New York, NY (PRWEB) November 20, 2012
A study by the CDC’s National Center for Health Statistics shows use of intrauterine devices such as NuvaRing are on the rise compared with condoms and traditional pills, according to a WebMD report on October 18, 2012. The study found use has grown by 700% since 1995.
The news comes as experts have linked vaginal rings like NuvaRing to increased risks of blood clots. The British Medical Journal published a study on May 10, 2012 linking vaginal rings like NuvaRing to as much as a 90% increased risk of blood clots over oral contraceptives. On June 14, 2012, the New England Journal of Medicine also published findings that vaginal ring contraceptives could relate to a 2.5 to 3-fold increased risk of blood clots.
So far, the FDA has received more than 1,000 reports of blood clot injury or death in patients using NuvaRing, according to an article in CBS News San Diego on September 21, 2012.
Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism after using NuvaRing is urged to visit the DrugRisk Resource Center or speak with a lawyer about their legal options.
Due to the number of patients filing a NuvaRing lawsuit, cases have been consolidated into a federal Multi-District Litigation court in Missouri. The formal case is known as In re: NuvaRing Products Liability Litigation, No. 08-md-1964, JPML, Eastern District Missouri.
Now, According to Legal Examiner on October 11, 2012, U.S. Federal District Judge Rodney W. Sippel announced on August 23rd that NuvaRing lawsuit trials would begin on May 6, 2013. This will set a precedent for other cases and settlements for future victims.
The DrugRisk Resource Center urges anyone affected by blood clots, stroke, DVT or pulmonary embolism after using NuvaRing to learn their legal rights as soon as possible.
Due to the specialized nature of federal MDL drug injury cases, the DrugRisk Resource Center only recommends lawyers and law firms who have already handled NuvaRing lawsuits.